- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 95,030 | 07.08.24 17:42:47 | +2,540 | +2,75% | 94,800 | 95,140 | 93,590 | 92,490 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 976,800 | 07.08.24 08:12:00 | -20,800 | -2,08% | 980,400 | 987,200 | 976,800 | 997,600 |
